D. Pinto

发表

Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo

Carolina Q. Sacramento, H. Castro-Faria-Neto, P. Bozza, 2021, bioRxiv.

Disulfiram repurposing in the combined chemotherapy of Chagas disease

A. Hasslocher-Moreno, R. Saraiva, M. Mediano, 2021, Medicine: Case Reports and Study Protocols.

Simple and rapid method determination for metformin in human plasma using high performance liquid chromatography tandem mass spectrometry: application to pharmacokinetic studies.

Olivia Woyames Pinto, E. Werneck-Barroso, D. Pinto, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after long-term immunosuppressive therapy

R. Marchevsky, M. C. C. da Silva, J. Morán, 2017, PloS one.

Using a single tablet daily to treat latent tuberculosis infection in Brazil: bioequivalence of two different isoniazid formulations (300 mg and 100 mg) demonstrated by a sensitive and rapid high-performance liquid chromatography-tandem mass spectrometry method in a randomised, crossover study

D. Barreira, A. Daher, D. Pinto, 2015, Memorias do Instituto Oswaldo Cruz.

Sofosbuvir shows a protective effect against vertical transmission of Zika virus and the associated congenital syndrome in rhesus monkeys.

R. Marchevsky, A. M. Alves, S. Lima, 2020, Antiviral research.

Post-marketing surveillance of generic amoxicillin using a microbiological assay and pharmacokinetic approach in rats.

F. Amendoeira, F. Ferraris, D. Pinto, 2016, International journal of antimicrobial agents.

Pharmacological Interaction of Lopinavir/Ritonavir 800/200 mg BID andRifampicin in Subjects Presenting Tuberculosis with Contraindication for an Efavirenz containing Antiretroviral Regimen

M. Morgado, A. Benjamin, D. Pinto, 2014 .

Safety, Efficacy and Pharmacokinetics of Ritonavir 400mg/Saquinavir 400mg Twice Daily plus Rifampicin Combined Therapy in HIV Patients with Tuberculosis

M. Lourenço, E. Werneck-Barroso, M. Morgado, 2006, Clinical drug investigation.

Preclinical pharmacokinetic evaluation of praziquantel loaded in poly (methyl methacrylate) nanoparticle using a HPLC-MS/MS.

J. Pinto, M. Nele, Jorge G. F. Santos, 2016, Journal of pharmaceutical and biomedical analysis.

Pharmacological profiling of JME-173, a novel mexiletine derivative combining dual anti-inflammatory/anti-spasmodic functions and limited action in Na+ channels.

M. Martins, O. Santos-Filho, R. Faria, 2020, European journal of pharmacology.

Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine

D. Lalloo, G. Aljayyoussi, M. Lacerda, 2019, Malaria Journal.

Analysis of 2′-hydroxyflavanone (2HF) in mouse whole blood by HPLC–MS/MS for the determination of pharmacokinetic parameters

E. Cunha-Junior, Luiza F O Gervazoni, Taiana Ferreira-Paes, 2023, Frontiers in Chemistry.

DETERMINATION OF LEVODOPA IN HUMAN PLASMA BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (HPLC-MS/MS): APPLICATION TO A BIOEQUIVALENCE STUDY

A. S. Marques, D. Pinto, A. Nascimento, 2013 .

Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine

D. Lalloo, G. Aljayyoussi, M. Lacerda, 2019, Malaria Journal.

Pharmacokinetics of chloroquine and primaquine in healthy volunteers

A. Daher, L. B. da Fonseca, D. Pinto, 2022, Malaria Journal.

Preclinical pharmacokinetic evaluation of praziquantel loaded in poly (methyl methacrylate) nanoparticle using a HPLC-MS/MS.

J. Pinto, M. Nele, Jorge G. F. Santos, 2016, Journal of pharmaceutical and biomedical analysis.